These findings showed that depletion of USP7 in ccRCC restrained tumor progression in vivo and in vitro, suggesting that USP7 may become a potential therapeutic target for ccRCC treatment. The gene discussed is USP7; the disease is nonpapillary renal cell carcinoma.